FDA APPROVES EXPANDED USE OF $BSX (BOSTON SCIENTIFIC) DEVICES

Typically we refrain from posting on this blog the information that is easily available elsewhere. In view of us taking…
Read more »
 

NOBLE ON $BSX

Noble Financial's checks at Boston Scientific indicate ICD's and CRT-Ds could return back to the market in 5 days versus…
Read more »

You are receiving less than 2% of the content from our paid services ...TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Check out our enviable performance in both bull and bear markets.

 

12.5% GAIN ON $BSX (BOSTON SCIENTIFIC) IN THE FACE OF SEVERAL BROKER DOWNGRADES

In spite of a negative article in Barron's Online and two new broker downgrades, we have gain at $ This…
Read more »
 

ANATOMY OF $BSX (BOSTON SCIENTIFIC), $MDT (MEDTRONIC) AND $STJ (ST. JUDE MEDICAL) TRADES BASED ON ZYX CHANGE METHOD

In ZYX Change Method, every trade must pass through six screens. In the first Change Screen, we are looking for…
Read more »

You are receiving less than 2% of the content from our paid services ...TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Check out our enviable performance in both bull and bear markets.

 

AS PER THE PRIOR POST, ADDED TO $MDT SHORT AT $46.00

THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND…
Read more »
 

AS PER THE PRIOR POST, SCALED IN A SHORT ON $STJ AT 40.70

THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND…
Read more »
 

AS PER THE PRIOR POST, SCALED IN LONG ON $BSX AT $6.32

THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND…
Read more »
 

SHORT SELL $STJ AND $MDT, BUY $BSX

$BSX is down substantially on FDA issues and competitors $MDT and $STJ have spiked up. These are minor paperwork issues…
Read more »
 

MORE EVIDENCE TO SUPPORT OUR THEORY OF DISINTERMEDIATION OF PHARMACY BENEFIT MANAGERS IN THE LONG TERM

We have been short with a very long term perspective on pharmacy benefit managers $MHS and $ESRX. The point of…
Read more »
 

TRADE MANAGEMENT UNDER ZYX CHANGE METHOD

Earlier today we sold $NFLX short at $ Shortly afterwards $NFLX was touted as a buy because of Cisco announcement.…
Read more »
Follow

Get every new post delivered to your Inbox

Join other followers

make money

316 WINNING TRADES

20 LOSING TRADES

1122.66% ANNUALIZED AVERAGE RETURN PER TRADE

..........CHECK OUT FREE TRIALS

START GENERATING WEALTH NOW!